For example, we and others have reported that the astrocytic biomarker YKL-40 and the Parkinson’s disease-related biomarker α-synuclein are strongly associated with P-tau181 in CSF, which was interpreted as that these brain pathological changes co-vary29–31. The gene discussed is CHI3L1; the disease is Parkinson disease.